Your partner in urology

Taking the lead in urology and urogynaecology

We are dedicated to improving the range of products available in Europe to treat urological conditions.

The prevalence of many urological conditions is increasing, largely as a result of the ageing population, and many of these represent major, unmet clinical needs.

Our mission is to be recognised as the leading urology and urogynaecology focused specialty pharmaceutical business in Europe, marketing products directly in the leading EU markets and through expert partners in other regions and countries.

The acquisition of Contura in 2013 is aligned to our strategy to focus in urology and urogynaecology and to expand our commercial geographical presence.

Find out more about Contura.

Working throughout Europe and beyond

Speciality European Pharma has its own commercial operations in the large European markets – the UK, Germany, France, Italy and the Nordic region.

SEP markets its products in other regions and territories through relationships with expert partners.

Our products



Regurin XL

Regurin BD



A team with a strong track record

Our team is highly experienced with a track record of success in bringing new products from the late stages of development, through the European regulatory processes, and on to the market. Speciality European Pharma has already demonstrated an ability to identify and acquire attractive late stage products

© 2006-2017 Speciality European Pharma | Site map